BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 17161253)

  • 21. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.
    Hirata T; Sugiyama D; Nagasawa SY; Murakami Y; Saitoh S; Okayama A; Iso H; Irie F; Sairenchi T; Miyamoto Y; Yamada M; Ishikawa S; Miura K; Ueshima H; Okamura T;
    Eur J Epidemiol; 2017 Jul; 32(7):547-557. PubMed ID: 27709448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major lipids, apolipoproteins, and risk of vascular disease.
    ; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
    JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study.
    Canouï-Poitrine F; Luc G; Bard JM; Ferrieres J; Yarnell J; Arveiler D; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P; Empana JP;
    Cerebrovasc Dis; 2010 Aug; 30(3):252-9. PubMed ID: 20664258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.
    Abdel-Maksoud MF; Eckel RH; Hamman RF; Hokanson JE
    J Clin Lipidol; 2012; 6(4):374-81. PubMed ID: 22836075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
    Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
    Nam BH; Kannel WB; D'Agostino RB
    Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: a 15-year follow-up of the Chinese Multi-provincial Cohort Study.
    Liu J; Wang W; Wang M; Sun J; Liu J; Li Y; Qi Y; Wu Z; Zhao D
    Diabetes Res Clin Pract; 2012 May; 96(2):217-24. PubMed ID: 22244364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
    Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
    Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women.
    Leening MJG; Cook NR; Franco OH; Manson JE; Lakshminarayan K; LaMonte MJ; Leira EC; Robinson JG; Ridker PM; Paynter NP
    J Am Heart Assoc; 2018 Oct; 7(19):e007514. PubMed ID: 30371339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.
    Pikula A; Beiser AS; Wang J; Himali JJ; Kelly-Hayes M; Kase CS; Yang Q; Seshadri S; Wolf PA
    Neurology; 2015 Feb; 84(5):472-9. PubMed ID: 25568296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical biomarkers of high-density lipoprotein dysfunction among middle-aged Turks.
    Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
    Anadolu Kardiyol Derg; 2012 Dec; 12(8):628-36. PubMed ID: 22968297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years.
    Simons LA; Simons J; Friedlander Y; McCallum J
    Atherosclerosis; 2001 Nov; 159(1):201-8. PubMed ID: 11689222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.